| dc.creator |
Trombetta-Lima, Marina |
|
| dc.creator |
Tsagkari, Dikaia |
|
| dc.creator |
Tzepapadaki, Afroditi |
|
| dc.creator |
Dolga, Amalia M. |
|
| dc.creator |
Kortholt, Arjan |
|
| dc.creator |
Soliman, Ahmed |
|
| dc.creator |
Oun, Asmaa |
|
| dc.date |
2022-12-01T00:00:00Z |
|
| dc.date.accessioned |
2023-01-09T12:09:14Z |
|
| dc.date.available |
2023-01-09T12:09:14Z |
|
| dc.identifier |
e58ec74c-4f8f-4db1-af26-cd5a448b53b2 |
|
| dc.identifier |
10.1016/j.nbd.2022.105917 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/e58ec74c-4f8f-4db1-af26-cd5a448b53b2/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/98481 |
|
| dc.description |
© 2022 The AuthorsFerroptosis is an iron-dependent regulated cell death pathway characterized by excessive lipid peroxidation. It is implicated in many neurodegenerative diseases, including Parkinson's Disease (PD). Mutations and increased leucine-rich repeat kinase 2 (LRRK2) kinase activity are associated with both familial and idiopathic PD pathology. Increased iron deposition was observed in the substantia nigra of LRRK2 mutation-carrying PD patients compared to healthy individuals, suggesting a potential link between LRRK2 and ferroptosis. However, the role of LRRK2 in the immune cells is still not well-understood. This study aims to investigate the effect of LRRK2 on ferroptosis-induced cell death in immune cells. We used LRRK2 parental (WT) and LRRK2 KO (KO) RAW 264.7 murine macrophages. Cells were challenged with the ferroptosis inducer, erastin, and the kinase activity was investigated using the LRRK2 kinase inhibitor, MLi2. Cell metabolism and viability analysis showed that WT cells were more resistant to ferroptosis than the KO cells. Lipid peroxidation and cellular reactive oxygen species (ROS) generation were significantly elevated in the KO cells. Furthermore, mitochondrial membrane potential and mitochondrial respiration were decreased in the KO cells after erastin treatment compared to the WT cells. Inhibition of the LRRK2 kinase function resulted in increased cell sensitivity to erastin. Cell and mitochondrial substrates utilization were altered in the KO and kinase inhibited WT cells compared to WT cells. These results indicate a protective role of LRRK2 against erastin-induced ferroptosis in RAW macrophages and point towards the importance of LRRK2 kinase function in the protective mechanism. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
LRRK2 protects immune cells against erastin-induced ferroptosis |
|
| dc.type |
info:eu-repo/semantics/article |
|